The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Growth in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 23,400 shares, a growth of 216.2% from the December 15th total of 7,400 shares. Based on an average trading volume of 28,300 shares, the days-to-cover ratio is presently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 2.5 %

CGABL stock traded up $0.45 during trading hours on Wednesday, hitting $18.44. 21,063 shares of the stock were exchanged, compared to its average volume of 35,107. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12 month low of $17.48 and a 12 month high of $20.85. The company has a 50-day simple moving average of $18.72 and a two-hundred day simple moving average of $19.14.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Saturday, February 15th. Investors of record on Saturday, February 1st will be given a $0.2891 dividend. The ex-dividend date of this dividend is Friday, January 31st. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.27%. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.